Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
Dorzolamide
PharmaSwiss Ceska republika s.r.o.
S01EC; S01EC03
Dorzolamide
20 milligram(s)/millilitre
Eye drops, solution
Product subject to prescription which may be renewed (B)
Carbonic anhydrase inhibitors; dorzolamide
Not marketed
2016-11-25
PACKAGE LEAFLET: INFORMATION FOR THE USER DORZOLAMIDE PHARMASWISS 20 MG/ML, EYE DROPS SOLUTION Dorzolamide hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Dorzolamide PharmaSwiss is and what it is used for 2. What you need to know before you use Dorzolamide PharmaSwiss 3. How to use Dorzolamide PharmaSwiss 4. Possible side effects 5. How to store Dorzolamide PharmaSwiss 6. Contents of the pack and other information 1. WHAT DORZOLAMIDE PHARMASWISS IS AND WHAT IT IS USED FOR Dorzolamide PharmaSwiss contains dorzolamide which belongs to a group of medicines called "carbonic anhydrase inhibitors". This medicine is prescribed to lower raised pressure in the eye and to treat glaucoma. This medicine can be used alone or in addition to other medicines which lower the pressure in the eye (so called beta-blockers). Dorzolamide PharmaSwiss eye drops solution is a sterile solution that does not contain a preservative. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE USE DORZOLAMIDE PHARMASWISS DO NOT USE DORZOLAMIDE PHARMASWISS if you are allergic to dorzolamide hydrochloride or any of the other ingredients of this medicine. if you have severe kidney impairment or problems, or a prior history of kidney stones. If you are not sure whether you should use this medicine, contact your doctor or pharmacist. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist or nurse before taking Dorzolamide PharmaSwiss Tell your doctor or pharmacist about any medical problems you have now or have ha Soma hati kamili
Health℃Products℃Regulatory℃Authority 12℃August℃2021 CRN00CD4Z Page℃1℃of℃8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dorzolamide℃PharmaSwiss℃20℃mg/ml℃eye℃drops℃solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each℃ml℃contains℃20℃mg℃of℃dorzolamide℃(as℃dorzolamide℃hydrochloride) For℃the℃full℃list℃of℃excipients,℃see℃section℃6.1. 3 PHARMACEUTICAL FORM Eye℃drops,℃solution℃ Clear,℃colourless,℃slightly℃viscous,℃aqueous℃solution℃with℃a℃pH℃between℃5.0℃and℃6.0℃and℃an℃osmolality℃of℃_270-310 _mOsM/Kg. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dorzolomide℃PharmaSwiss℃eye℃drops℃solution℃is℃indicated: as℃adjunctive℃therapy℃to℃beta-blockers,℃ as℃monotherapy℃in℃patients℃unresponsive℃to℃beta-blockers℃or℃in℃whom℃beta-℃blockers℃are℃contraindicated, in℃the℃treatment℃of℃elevated℃intra-ocular℃pressure℃in: ocular℃hypertension, open-angle℃glaucoma, pseudoexfoliative℃glaucoma. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology When℃used℃as℃monotherapy,℃the℃dose℃is℃one℃drop℃of℃dorzolamide℃in℃the℃conjunctival℃sac℃of℃the℃affected℃eye(s),℃three℃times℃ daily. When℃used℃as℃adjunctive℃therapy℃with℃an℃ophthalmic℃beta-blocker,℃the℃dose℃is℃one℃drop℃of℃dorzolamide℃in℃the℃conjunctival℃sac℃ of℃the℃affected℃eye(s)℃two℃times℃daily. When℃substituting℃dorzolamide℃for℃another℃ophthalmic℃anti-glaucoma℃agent,℃discontinue℃the℃other℃agent℃after℃proper℃dosing℃ on℃one℃day,℃and℃start℃dorzolamide℃on℃the℃next℃day. If℃more℃than℃one℃topical℃ophthalmic℃drug℃is℃being℃used,℃the℃drugs℃should℃be℃administered℃at℃least℃ten℃minutes℃apart. Patients℃should℃be℃instructed℃to℃wash℃their℃hands℃before℃use℃and℃avoid℃allowing℃the℃tip℃of℃the℃container Soma hati kamili